

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 5.27405059 |
| 2 | cullin deneddylation (GO:0010388) | 4.69865298 |
| 3 | protein deneddylation (GO:0000338) | 4.05971594 |
| 4 | DNA ligation (GO:0006266) | 4.00062523 |
| 5 | establishment of integrated proviral latency (GO:0075713) | 3.95288259 |
| 6 | DNA deamination (GO:0045006) | 3.93487814 |
| 7 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.88761174 |
| 8 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.83943694 |
| 9 | regulation of coenzyme metabolic process (GO:0051196) | 3.82386385 |
| 10 | regulation of cofactor metabolic process (GO:0051193) | 3.82386385 |
| 11 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.81609435 |
| 12 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.78867764 |
| 13 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.74598375 |
| 14 | purine nucleobase biosynthetic process (GO:0009113) | 3.73910851 |
| 15 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.69010627 |
| 16 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.69010627 |
| 17 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.69010627 |
| 18 | platelet dense granule organization (GO:0060155) | 3.68389249 |
| 19 | ribosome assembly (GO:0042255) | 3.66798909 |
| 20 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.65301234 |
| 21 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.65301234 |
| 22 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.63381711 |
| 23 | tricarboxylic acid cycle (GO:0006099) | 3.61859173 |
| 24 | non-recombinational repair (GO:0000726) | 3.60588031 |
| 25 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.60588031 |
| 26 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.57416655 |
| 27 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.57416655 |
| 28 | respiratory chain complex IV assembly (GO:0008535) | 3.55959772 |
| 29 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.55017934 |
| 30 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.51008094 |
| 31 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.45466383 |
| 32 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.45466383 |
| 33 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.44071301 |
| 34 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.43344967 |
| 35 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.43344967 |
| 36 | isotype switching (GO:0045190) | 3.43344967 |
| 37 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.42929126 |
| 38 | negative regulation of fibroblast apoptotic process (GO:2000270) | 3.40674321 |
| 39 | nuclear pore organization (GO:0006999) | 3.36310718 |
| 40 | histone H2A acetylation (GO:0043968) | 3.34578866 |
| 41 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.32902462 |
| 42 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.32902462 |
| 43 | positive regulation of ligase activity (GO:0051351) | 3.30182429 |
| 44 | negative regulation of DNA recombination (GO:0045910) | 3.29134279 |
| 45 | histone mRNA metabolic process (GO:0008334) | 3.27892851 |
| 46 | mitotic metaphase plate congression (GO:0007080) | 3.24138208 |
| 47 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.22701475 |
| 48 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.22701475 |
| 49 | histone exchange (GO:0043486) | 3.19602637 |
| 50 | replication fork processing (GO:0031297) | 3.19142027 |
| 51 | response to X-ray (GO:0010165) | 3.18996850 |
| 52 | nucleobase biosynthetic process (GO:0046112) | 3.18383902 |
| 53 | negative regulation of DNA repair (GO:0045738) | 3.14688624 |
| 54 | rRNA modification (GO:0000154) | 3.13611562 |
| 55 | branched-chain amino acid catabolic process (GO:0009083) | 3.11490369 |
| 56 | establishment of viral latency (GO:0019043) | 3.07269852 |
| 57 | regulation of helicase activity (GO:0051095) | 3.01760347 |
| 58 | mitotic sister chromatid segregation (GO:0000070) | 3.01647558 |
| 59 | * protein neddylation (GO:0045116) | 3.00283530 |
| 60 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.99843484 |
| 61 | lactate metabolic process (GO:0006089) | 2.99569208 |
| 62 | DNA double-strand break processing (GO:0000729) | 2.98119988 |
| 63 | sister chromatid segregation (GO:0000819) | 2.96253656 |
| 64 | rRNA methylation (GO:0031167) | 2.94920298 |
| 65 | regulation of ligase activity (GO:0051340) | 2.94892650 |
| 66 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.94801090 |
| 67 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.93104804 |
| 68 | metaphase plate congression (GO:0051310) | 2.91444158 |
| 69 | mitochondrial RNA metabolic process (GO:0000959) | 2.88173083 |
| 70 | regulation of translational termination (GO:0006449) | 2.88000794 |
| 71 | chondrocyte proliferation (GO:0035988) | 2.87880523 |
| 72 | regulation of fibroblast apoptotic process (GO:2000269) | 2.86546294 |
| 73 | cytochrome complex assembly (GO:0017004) | 2.86531945 |
| 74 | protein K11-linked ubiquitination (GO:0070979) | 2.84664663 |
| 75 | positive regulation of mitochondrial fission (GO:0090141) | 2.83270324 |
| 76 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.82025352 |
| 77 | negative regulation of protein ubiquitination (GO:0031397) | 2.82025267 |
| 78 | positive regulation of actin filament depolymerization (GO:0030836) | 2.80256428 |
| 79 | regulation of sulfur metabolic process (GO:0042762) | 2.79818414 |
| 80 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.77430137 |
| 81 | sequestering of actin monomers (GO:0042989) | 2.75292924 |
| 82 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.75146988 |
| 83 | mismatch repair (GO:0006298) | 2.74838142 |
| 84 | DNA replication-independent nucleosome organization (GO:0034724) | 2.74154184 |
| 85 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.74154184 |
| 86 | anterograde synaptic vesicle transport (GO:0048490) | 2.73676242 |
| 87 | histone mRNA catabolic process (GO:0071044) | 2.73572241 |
| 88 | protein-cofactor linkage (GO:0018065) | 2.72868307 |
| 89 | somatic diversification of immunoglobulins (GO:0016445) | 2.72474432 |
| 90 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.71018891 |
| 91 | resolution of meiotic recombination intermediates (GO:0000712) | 2.70798238 |
| 92 | organelle disassembly (GO:1903008) | 2.70651166 |
| 93 | IMP biosynthetic process (GO:0006188) | 2.70540919 |
| 94 | cytidine deamination (GO:0009972) | 2.69956904 |
| 95 | cytidine catabolic process (GO:0006216) | 2.69956904 |
| 96 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.69393395 |
| 97 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.68880195 |
| 98 | protein prenylation (GO:0018342) | 2.68734421 |
| 99 | prenylation (GO:0097354) | 2.68734421 |
| 100 | peptidyl-arginine N-methylation (GO:0035246) | 2.68570234 |
| 101 | peptidyl-arginine methylation (GO:0018216) | 2.68570234 |
| 102 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.66622159 |
| 103 | ventricular cardiac muscle cell development (GO:0055015) | 2.65935594 |
| 104 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.64099505 |
| 105 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.63429063 |
| 106 | positive regulation of protein complex disassembly (GO:0043243) | 2.62192821 |
| 107 | establishment of chromosome localization (GO:0051303) | 2.61865152 |
| 108 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.58395044 |
| 109 | apical protein localization (GO:0045176) | 2.58171295 |
| 110 | IMP metabolic process (GO:0046040) | 2.57390616 |
| 111 | nuclear pore complex assembly (GO:0051292) | 2.55915784 |
| 112 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.55816762 |
| 113 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.55816762 |
| 114 | regulation of centriole replication (GO:0046599) | 2.55346992 |
| 115 | spindle checkpoint (GO:0031577) | 2.54215794 |
| 116 | chaperone-mediated protein transport (GO:0072321) | 2.53576348 |
| 117 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.52700532 |
| 118 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.52525121 |
| 119 | CENP-A containing nucleosome assembly (GO:0034080) | 2.51304969 |
| 120 | regulation of centrosome cycle (GO:0046605) | 2.50677946 |
| 121 | glutamate secretion (GO:0014047) | 2.49186214 |
| 122 | histone arginine methylation (GO:0034969) | 2.49090794 |
| 123 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.48208743 |
| 124 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.47049886 |
| 125 | spindle assembly checkpoint (GO:0071173) | 2.46616626 |
| 126 | mitotic spindle assembly checkpoint (GO:0007094) | 2.46155089 |
| 127 | transferrin transport (GO:0033572) | 2.45571126 |
| 128 | chromatin remodeling at centromere (GO:0031055) | 2.45085011 |
| 129 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.43929808 |
| 130 | inositol phosphate catabolic process (GO:0071545) | 2.43459329 |
| 131 | mitotic spindle checkpoint (GO:0071174) | 2.43305409 |
| 132 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 2.42558874 |
| 133 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.41921067 |
| 134 | trivalent inorganic cation transport (GO:0072512) | 2.38284147 |
| 135 | ferric iron transport (GO:0015682) | 2.38284147 |
| 136 | regulation of sister chromatid segregation (GO:0033045) | 2.36886916 |
| 137 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.36886916 |
| 138 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.36886916 |
| 139 | regulation of centrosome duplication (GO:0010824) | 2.36317882 |
| 140 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.35632073 |
| 141 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.35632073 |
| 142 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.35632073 |
| 143 | negative regulation of sister chromatid segregation (GO:0033046) | 2.35632073 |
| 144 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 2.34597272 |
| 145 | regulation of mitochondrial fission (GO:0090140) | 2.33471823 |
| 146 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.33462846 |
| 147 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.33462846 |
| 148 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.33462846 |
| 149 | positive regulation of cardiac muscle tissue development (GO:0055025) | 2.30661837 |
| 150 | mitotic sister chromatid cohesion (GO:0007064) | 2.30080643 |
| 151 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.29763908 |
| 152 | paraxial mesoderm development (GO:0048339) | 2.29505154 |
| 153 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.28990751 |
| 154 | positive regulation of muscle hypertrophy (GO:0014742) | 2.28930455 |
| 155 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.28930455 |
| 156 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.27704919 |
| 157 | mitochondrial genome maintenance (GO:0000002) | 2.27559691 |
| 158 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.27001344 |
| 159 | regulation of mitotic spindle organization (GO:0060236) | 2.26972885 |
| 160 | negative regulation of chromosome segregation (GO:0051985) | 2.26195544 |
| 161 | positive regulation of protein depolymerization (GO:1901881) | 2.25919243 |
| 162 | mitotic cytokinesis (GO:0000281) | 2.25500420 |
| 163 | negative regulation of ligase activity (GO:0051352) | 2.24956790 |
| 164 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.24956790 |
| 165 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.24607199 |
| 166 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.23439635 |
| 167 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.19613782 |
| 168 | axon extension involved in axon guidance (GO:0048846) | 2.19613782 |
| 169 | positive regulation of heart growth (GO:0060421) | 2.18273474 |
| 170 | ATP synthesis coupled proton transport (GO:0015986) | 2.17963071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 4.17021222 |
| 2 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.08161052 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.97795650 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.97584357 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.91897159 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.82600841 |
| 7 | FUS_26573619_Chip-Seq_HEK293_Human | 2.82363652 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.53835781 |
| 9 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.49592713 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.47103076 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.43665315 |
| 12 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.36079696 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.33726574 |
| 14 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.22334837 |
| 15 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.18901465 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.16409577 |
| 17 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.08542254 |
| 18 | EWS_26573619_Chip-Seq_HEK293_Human | 2.06187695 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.05083459 |
| 20 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.04687088 |
| 21 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.04628793 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.02183044 |
| 23 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.00588880 |
| 24 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.97018320 |
| 25 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.93878042 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.85948502 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.83124507 |
| 28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.79912568 |
| 29 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.79778639 |
| 30 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.75181304 |
| 31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.73854214 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.73652311 |
| 33 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.68959325 |
| 34 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67481252 |
| 35 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.66717869 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.66390744 |
| 37 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.65727831 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.65641238 |
| 39 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.63991143 |
| 40 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.62216331 |
| 41 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61673303 |
| 42 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.54840815 |
| 43 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.54181817 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52599544 |
| 45 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.51398361 |
| 46 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.50784116 |
| 47 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.47636459 |
| 48 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.46671432 |
| 49 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.42797421 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.42707862 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.41378668 |
| 52 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.41071399 |
| 53 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.41051543 |
| 54 | JUN_21703547_ChIP-Seq_K562_Human | 1.40532939 |
| 55 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.38937906 |
| 56 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.38920919 |
| 57 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.38874513 |
| 58 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33865705 |
| 59 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33269386 |
| 60 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.30575264 |
| 61 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.30502371 |
| 62 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.29868921 |
| 63 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.29815023 |
| 64 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29572613 |
| 65 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.28852130 |
| 66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.25085302 |
| 67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.25085302 |
| 68 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.24451679 |
| 69 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.24252597 |
| 70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23279986 |
| 71 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.23114576 |
| 72 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.22746196 |
| 73 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.22427497 |
| 74 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.21488607 |
| 75 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.21287954 |
| 76 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21169461 |
| 77 | VDR_22108803_ChIP-Seq_LS180_Human | 1.20135634 |
| 78 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.20132198 |
| 79 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.18680896 |
| 80 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.18348255 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.17206043 |
| 82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16118981 |
| 83 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.15495360 |
| 84 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.14243388 |
| 85 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.13520081 |
| 86 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.13163196 |
| 87 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.12695349 |
| 88 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.12496812 |
| 89 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.12401718 |
| 90 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12257234 |
| 91 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.11836677 |
| 92 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.11482053 |
| 93 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.11303936 |
| 94 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10778208 |
| 95 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10486533 |
| 96 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09930705 |
| 97 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.08670914 |
| 98 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07119250 |
| 99 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.06835063 |
| 100 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06226574 |
| 101 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05406226 |
| 102 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04693647 |
| 103 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04693647 |
| 104 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.03413864 |
| 105 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03298685 |
| 106 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03152756 |
| 107 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03152756 |
| 108 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.02826680 |
| 109 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02445475 |
| 110 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.02278176 |
| 111 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.01537511 |
| 112 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.01384749 |
| 113 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.01308917 |
| 114 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.01182098 |
| 115 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.00779612 |
| 116 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.00209577 |
| 117 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99696920 |
| 118 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99359478 |
| 119 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99000356 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98681834 |
| 121 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.98407173 |
| 122 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.98089489 |
| 123 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.97888865 |
| 124 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97791596 |
| 125 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97571161 |
| 126 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.97303904 |
| 127 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.97159740 |
| 128 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.97057543 |
| 129 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96725753 |
| 130 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.96200248 |
| 131 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96175929 |
| 132 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.95736331 |
| 133 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.95715176 |
| 134 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95674701 |
| 135 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.95574304 |
| 136 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95532966 |
| 137 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.95454882 |
| 138 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.95437108 |
| 139 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93978411 |
| 140 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93748903 |
| 141 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93496155 |
| 142 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.93270581 |
| 143 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.93144559 |
| 144 | AR_25329375_ChIP-Seq_VCAP_Human | 0.92584528 |
| 145 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.92474697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008058_abnormal_DNA_repair | 4.16745183 |
| 2 | MP0003123_paternal_imprinting | 3.20204440 |
| 3 | MP0006054_spinal_hemorrhage | 2.78725065 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 2.61675877 |
| 5 | MP0005503_abnormal_tendon_morphology | 2.56582543 |
| 6 | MP0008057_abnormal_DNA_replication | 2.36362798 |
| 7 | MP0003718_maternal_effect | 2.28624300 |
| 8 | MP0006072_abnormal_retinal_apoptosis | 2.24861282 |
| 9 | MP0003121_genomic_imprinting | 2.24069724 |
| 10 | MP0005075_abnormal_melanosome_morpholog | 2.22669975 |
| 11 | MP0003786_premature_aging | 2.19968005 |
| 12 | MP0001984_abnormal_olfaction | 2.17483588 |
| 13 | MP0003122_maternal_imprinting | 2.16323709 |
| 14 | MP0003693_abnormal_embryo_hatching | 2.13674583 |
| 15 | MP0008789_abnormal_olfactory_epithelium | 2.09293299 |
| 16 | MP0009384_cardiac_valve_regurgitation | 2.05833056 |
| 17 | MP0004084_abnormal_cardiac_muscle | 1.96377391 |
| 18 | MP0005171_absent_coat_pigmentation | 1.95966448 |
| 19 | MP0003787_abnormal_imprinting | 1.90843055 |
| 20 | MP0002735_abnormal_chemical_nociception | 1.89341197 |
| 21 | MP0001299_abnormal_eye_distance/ | 1.82345877 |
| 22 | MP0005623_abnormal_meninges_morphology | 1.81830032 |
| 23 | MP0003880_abnormal_central_pattern | 1.74069259 |
| 24 | MP0003195_calcinosis | 1.70307547 |
| 25 | MP0005253_abnormal_eye_physiology | 1.69719726 |
| 26 | MP0005275_abnormal_skin_tensile | 1.69312620 |
| 27 | MP0003186_abnormal_redox_activity | 1.67982483 |
| 28 | MP0009046_muscle_twitch | 1.66461249 |
| 29 | MP0000537_abnormal_urethra_morphology | 1.64924291 |
| 30 | MP0006035_abnormal_mitochondrial_morpho | 1.63028367 |
| 31 | MP0005084_abnormal_gallbladder_morpholo | 1.62304825 |
| 32 | MP0004233_abnormal_muscle_weight | 1.60719600 |
| 33 | MP0001968_abnormal_touch/_nociception | 1.58749850 |
| 34 | MP0010094_abnormal_chromosome_stability | 1.58225168 |
| 35 | MP0006036_abnormal_mitochondrial_physio | 1.57980579 |
| 36 | MP0002736_abnormal_nociception_after | 1.52097633 |
| 37 | MP0009697_abnormal_copulation | 1.52050378 |
| 38 | MP0004215_abnormal_myocardial_fiber | 1.49815335 |
| 39 | MP0001529_abnormal_vocalization | 1.49554463 |
| 40 | MP0000749_muscle_degeneration | 1.47031663 |
| 41 | MP0001835_abnormal_antigen_presentation | 1.45507062 |
| 42 | MP0003950_abnormal_plasma_membrane | 1.45091088 |
| 43 | MP0000751_myopathy | 1.42460465 |
| 44 | MP0001188_hyperpigmentation | 1.41156484 |
| 45 | MP0003724_increased_susceptibility_to | 1.40939636 |
| 46 | MP0009250_abnormal_appendicular_skeleto | 1.39955045 |
| 47 | MP0000372_irregular_coat_pigmentation | 1.38526798 |
| 48 | * MP0008932_abnormal_embryonic_tissue | 1.38402581 |
| 49 | MP0003937_abnormal_limbs/digits/tail_de | 1.36295891 |
| 50 | MP0004859_abnormal_synaptic_plasticity | 1.35333555 |
| 51 | MP0005394_taste/olfaction_phenotype | 1.34373861 |
| 52 | MP0005499_abnormal_olfactory_system | 1.34373861 |
| 53 | MP0005671_abnormal_response_to | 1.33098862 |
| 54 | * MP0004957_abnormal_blastocyst_morpholog | 1.32881014 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 1.28322231 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.27598056 |
| 57 | MP0004272_abnormal_basement_membrane | 1.26854735 |
| 58 | MP0004270_analgesia | 1.26048165 |
| 59 | MP0003385_abnormal_body_wall | 1.25280569 |
| 60 | MP0004484_altered_response_of | 1.24369309 |
| 61 | MP0003890_abnormal_embryonic-extraembry | 1.22035636 |
| 62 | MP0002734_abnormal_mechanical_nocicepti | 1.21694444 |
| 63 | MP0002282_abnormal_trachea_morphology | 1.20273524 |
| 64 | MP0004036_abnormal_muscle_relaxation | 1.17782727 |
| 65 | MP0003755_abnormal_palate_morphology | 1.17382446 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 1.16880261 |
| 67 | MP0002108_abnormal_muscle_morphology | 1.16455520 |
| 68 | MP0009745_abnormal_behavioral_response | 1.15919688 |
| 69 | MP0001485_abnormal_pinna_reflex | 1.14919689 |
| 70 | MP0002938_white_spotting | 1.14054345 |
| 71 | MP0002972_abnormal_cardiac_muscle | 1.13812367 |
| 72 | MP0002102_abnormal_ear_morphology | 1.13644477 |
| 73 | MP0005646_abnormal_pituitary_gland | 1.13520066 |
| 74 | MP0006276_abnormal_autonomic_nervous | 1.13463658 |
| 75 | MP0008877_abnormal_DNA_methylation | 1.12737285 |
| 76 | MP0009785_altered_susceptibility_to | 1.12725211 |
| 77 | MP0002006_tumorigenesis | 1.12389922 |
| 78 | MP0002064_seizures | 1.11273632 |
| 79 | MP0004134_abnormal_chest_morphology | 1.10676201 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 1.10341534 |
| 81 | MP0003635_abnormal_synaptic_transmissio | 1.07110271 |
| 82 | MP0001293_anophthalmia | 1.06197987 |
| 83 | MP0010030_abnormal_orbit_morphology | 1.06126873 |
| 84 | * MP0003077_abnormal_cell_cycle | 1.05223425 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 1.04998153 |
| 86 | MP0002877_abnormal_melanocyte_morpholog | 1.04458612 |
| 87 | MP0002063_abnormal_learning/memory/cond | 1.02665859 |
| 88 | MP0002166_altered_tumor_susceptibility | 1.00808621 |
| 89 | MP0003221_abnormal_cardiomyocyte_apopto | 1.00749837 |
| 90 | MP0000778_abnormal_nervous_system | 1.00587259 |
| 91 | MP0003941_abnormal_skin_development | 0.99159219 |
| 92 | MP0008007_abnormal_cellular_replicative | 0.98106318 |
| 93 | MP0003137_abnormal_impulse_conducting | 0.97988823 |
| 94 | MP0005620_abnormal_muscle_contractility | 0.97963680 |
| 95 | MP0009053_abnormal_anal_canal | 0.97901106 |
| 96 | MP0008775_abnormal_heart_ventricle | 0.97398077 |
| 97 | MP0001440_abnormal_grooming_behavior | 0.95764514 |
| 98 | MP0002233_abnormal_nose_morphology | 0.95452057 |
| 99 | MP0003111_abnormal_nucleus_morphology | 0.95297059 |
| 100 | MP0000013_abnormal_adipose_tissue | 0.94961426 |
| 101 | MP0004197_abnormal_fetal_growth/weight/ | 0.94389733 |
| 102 | MP0002184_abnormal_innervation | 0.92538032 |
| 103 | MP0002272_abnormal_nervous_system | 0.92240119 |
| 104 | MP0002090_abnormal_vision | 0.91930356 |
| 105 | MP0005508_abnormal_skeleton_morphology | 0.91260153 |
| 106 | MP0000428_abnormal_craniofacial_morphol | 0.90925679 |
| 107 | MP0001730_embryonic_growth_arrest | 0.90396216 |
| 108 | MP0001853_heart_inflammation | 0.89590718 |
| 109 | MP0006138_congestive_heart_failure | 0.88930774 |
| 110 | MP0002572_abnormal_emotion/affect_behav | 0.88526146 |
| 111 | MP0000647_abnormal_sebaceous_gland | 0.87596523 |
| 112 | MP0002067_abnormal_sensory_capabilities | 0.87593241 |
| 113 | MP0003942_abnormal_urinary_system | 0.87558300 |
| 114 | MP0000566_synostosis | 0.87280442 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.86686232 |
| 116 | MP0005367_renal/urinary_system_phenotyp | 0.86451804 |
| 117 | MP0000516_abnormal_urinary_system | 0.86451804 |
| 118 | MP0005386_behavior/neurological_phenoty | 0.86319239 |
| 119 | MP0004924_abnormal_behavior | 0.86319239 |
| 120 | MP0001764_abnormal_homeostasis | 0.84670862 |
| 121 | MP0000689_abnormal_spleen_morphology | 0.84587602 |
| 122 | MP0000350_abnormal_cell_proliferation | 0.83807573 |
| 123 | MP0001697_abnormal_embryo_size | 0.81203878 |
| 124 | MP0000762_abnormal_tongue_morphology | 0.80788328 |
| 125 | MP0003567_abnormal_fetal_cardiomyocyte | 0.80467387 |
| 126 | MP0005395_other_phenotype | 0.79206229 |
| 127 | MP0001929_abnormal_gametogenesis | 0.78227314 |
| 128 | MP0001324_abnormal_eye_pigmentation | 0.77798218 |
| 129 | MP0005369_muscle_phenotype | 0.77421326 |
| 130 | MP0001119_abnormal_female_reproductive | 0.77409442 |
| 131 | MP0008995_early_reproductive_senescence | 0.77180362 |
| 132 | MP0002751_abnormal_autonomic_nervous | 0.77148080 |
| 133 | MP0010307_abnormal_tumor_latency | 0.76916918 |
| 134 | MP0005408_hypopigmentation | 0.76651465 |
| 135 | MP0001177_atelectasis | 0.76597853 |
| 136 | MP0002019_abnormal_tumor_incidence | 0.76373555 |
| 137 | MP0003646_muscle_fatigue | 0.76059494 |
| 138 | MP0002177_abnormal_outer_ear | 0.75829904 |
| 139 | MP0000358_abnormal_cell_content/ | 0.75549653 |
| 140 | MP0002277_abnormal_respiratory_mucosa | 0.75417163 |
| 141 | MP0009764_decreased_sensitivity_to | 0.75413820 |
| 142 | MP0002084_abnormal_developmental_patter | 0.75393171 |
| 143 | MP0005380_embryogenesis_phenotype | 0.75068814 |
| 144 | MP0001672_abnormal_embryogenesis/_devel | 0.75068814 |
| 145 | MP0002114_abnormal_axial_skeleton | 0.74898780 |
| 146 | MP0002396_abnormal_hematopoietic_system | 0.74167011 |
| 147 | MP0003984_embryonic_growth_retardation | 0.73953600 |
| 148 | MP0008873_increased_physiological_sensi | 0.73682772 |
| 149 | MP0000465_gastrointestinal_hemorrhage | 0.73359118 |
| 150 | MP0009765_abnormal_xenobiotic_induced | 0.70701128 |
| 151 | MP0004147_increased_porphyrin_level | 0.70616899 |
| 152 | MP0003136_yellow_coat_color | 0.68167800 |
| 153 | MP0002095_abnormal_skin_pigmentation | 0.66106785 |
| 154 | MP0002148_abnormal_hypersensitivity_rea | 0.64282990 |
| 155 | MP0003011_delayed_dark_adaptation | 0.62284218 |
| 156 | MP0000313_abnormal_cell_death | 0.61726576 |
| 157 | MP0004142_abnormal_muscle_tone | 0.61112117 |
| 158 | MP0000653_abnormal_sex_gland | 0.60481112 |
| 159 | MP0002234_abnormal_pharynx_morphology | 0.58704429 |
| 160 | MP0002722_abnormal_immune_system | 0.58413975 |
| 161 | MP0006292_abnormal_olfactory_placode | 0.57892834 |
| 162 | MP0004085_abnormal_heartbeat | 0.57628668 |
| 163 | MP0005174_abnormal_tail_pigmentation | 0.57303495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolysis (HP:0004366) | 4.15955135 |
| 2 | Increased serum pyruvate (HP:0003542) | 4.15955135 |
| 3 | Abnormality of the labia minora (HP:0012880) | 3.68310776 |
| 4 | Atonic seizures (HP:0010819) | 3.65507914 |
| 5 | Medial flaring of the eyebrow (HP:0010747) | 2.95836927 |
| 6 | Focal motor seizures (HP:0011153) | 2.95732388 |
| 7 | Methylmalonic acidemia (HP:0002912) | 2.93319367 |
| 8 | Renal cortical cysts (HP:0000803) | 2.80948365 |
| 9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.68372126 |
| 10 | Acute necrotizing encephalopathy (HP:0006965) | 2.67701521 |
| 11 | Abnormality of alanine metabolism (HP:0010916) | 2.64691817 |
| 12 | Hyperalaninemia (HP:0003348) | 2.64691817 |
| 13 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.64691817 |
| 14 | Pancreatic cysts (HP:0001737) | 2.62956885 |
| 15 | Epileptic encephalopathy (HP:0200134) | 2.62099002 |
| 16 | Increased hepatocellular lipid droplets (HP:0006565) | 2.59133269 |
| 17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.57107758 |
| 18 | Ependymoma (HP:0002888) | 2.54512157 |
| 19 | Volvulus (HP:0002580) | 2.50149327 |
| 20 | Progressive macrocephaly (HP:0004481) | 2.45944705 |
| 21 | Protrusio acetabuli (HP:0003179) | 2.40771436 |
| 22 | Shoulder girdle muscle weakness (HP:0003547) | 2.37918400 |
| 23 | True hermaphroditism (HP:0010459) | 2.37477544 |
| 24 | Nephrogenic diabetes insipidus (HP:0009806) | 2.36599823 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 2.35595432 |
| 26 | Premature rupture of membranes (HP:0001788) | 2.31034742 |
| 27 | Hyperglycinemia (HP:0002154) | 2.29907386 |
| 28 | Fetal akinesia sequence (HP:0001989) | 2.27508297 |
| 29 | Cerebral edema (HP:0002181) | 2.26660796 |
| 30 | Abnormality of serum amino acid levels (HP:0003112) | 2.26575519 |
| 31 | Pancreatic fibrosis (HP:0100732) | 2.25582779 |
| 32 | Neoplasm of the adrenal gland (HP:0100631) | 2.24901627 |
| 33 | 3-Methylglutaconic aciduria (HP:0003535) | 2.23471878 |
| 34 | Abolished electroretinogram (ERG) (HP:0000550) | 2.23435690 |
| 35 | Rhabdomyosarcoma (HP:0002859) | 2.22790816 |
| 36 | Methylmalonic aciduria (HP:0012120) | 2.22580897 |
| 37 | Pheochromocytoma (HP:0002666) | 2.18682177 |
| 38 | Lipid accumulation in hepatocytes (HP:0006561) | 2.18225169 |
| 39 | Exercise-induced muscle cramps (HP:0003710) | 2.17407187 |
| 40 | Increased serum lactate (HP:0002151) | 2.17101835 |
| 41 | Abnormality of the anterior horn cell (HP:0006802) | 2.16071226 |
| 42 | Degeneration of anterior horn cells (HP:0002398) | 2.16071226 |
| 43 | Gonadotropin excess (HP:0000837) | 2.14378061 |
| 44 | Abnormality of the renal cortex (HP:0011035) | 2.13542367 |
| 45 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.13198699 |
| 46 | Abnormality of chromosome stability (HP:0003220) | 2.12361436 |
| 47 | Thyroiditis (HP:0100646) | 2.10740581 |
| 48 | Severe combined immunodeficiency (HP:0004430) | 2.09886343 |
| 49 | Hyperventilation (HP:0002883) | 2.09836223 |
| 50 | Medulloblastoma (HP:0002885) | 2.08337831 |
| 51 | Increased CSF lactate (HP:0002490) | 2.07646355 |
| 52 | Febrile seizures (HP:0002373) | 2.07380191 |
| 53 | Resting tremor (HP:0002322) | 2.07224445 |
| 54 | Wrist flexion contracture (HP:0001239) | 2.07210049 |
| 55 | Abnormal hair whorl (HP:0010721) | 2.07154338 |
| 56 | Genital tract atresia (HP:0001827) | 2.07112868 |
| 57 | Lactic acidosis (HP:0003128) | 2.06845806 |
| 58 | Delayed gross motor development (HP:0002194) | 2.05431266 |
| 59 | Absence seizures (HP:0002121) | 2.03672954 |
| 60 | Neuroendocrine neoplasm (HP:0100634) | 2.02330681 |
| 61 | Vaginal atresia (HP:0000148) | 2.01707574 |
| 62 | Type I transferrin isoform profile (HP:0003642) | 1.99841998 |
| 63 | Abnormality of midbrain morphology (HP:0002418) | 1.99386600 |
| 64 | Molar tooth sign on MRI (HP:0002419) | 1.99386600 |
| 65 | Palpitations (HP:0001962) | 1.98816786 |
| 66 | Microglossia (HP:0000171) | 1.98651660 |
| 67 | Hypoglycemic coma (HP:0001325) | 1.98218443 |
| 68 | Abnormal lung lobation (HP:0002101) | 1.97749498 |
| 69 | IgG deficiency (HP:0004315) | 1.96054489 |
| 70 | Combined immunodeficiency (HP:0005387) | 1.95335847 |
| 71 | Irregular epiphyses (HP:0010582) | 1.94154647 |
| 72 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.94137666 |
| 73 | Abnormality of glycine metabolism (HP:0010895) | 1.94137666 |
| 74 | Abnormality of T cell number (HP:0011839) | 1.93292023 |
| 75 | Insidious onset (HP:0003587) | 1.92692248 |
| 76 | Termporal pattern (HP:0011008) | 1.92692248 |
| 77 | Cortical dysplasia (HP:0002539) | 1.92645068 |
| 78 | Akinesia (HP:0002304) | 1.92340696 |
| 79 | Aplastic anemia (HP:0001915) | 1.92106684 |
| 80 | Amyotrophic lateral sclerosis (HP:0007354) | 1.91860063 |
| 81 | Poor suck (HP:0002033) | 1.91749542 |
| 82 | Hypoglycemic seizures (HP:0002173) | 1.91687911 |
| 83 | Hypoplastic heart (HP:0001961) | 1.91143379 |
| 84 | Mitochondrial inheritance (HP:0001427) | 1.91025991 |
| 85 | Abnormal protein glycosylation (HP:0012346) | 1.90707902 |
| 86 | Abnormal glycosylation (HP:0012345) | 1.90707902 |
| 87 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.90707902 |
| 88 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.90707902 |
| 89 | Progressive inability to walk (HP:0002505) | 1.90578265 |
| 90 | T lymphocytopenia (HP:0005403) | 1.89647723 |
| 91 | Postnatal microcephaly (HP:0005484) | 1.88937126 |
| 92 | Mild short stature (HP:0003502) | 1.88717943 |
| 93 | Focal seizures (HP:0007359) | 1.88487802 |
| 94 | Abnormality of B cell number (HP:0010975) | 1.88383515 |
| 95 | Abnormality of the fovea (HP:0000493) | 1.86659976 |
| 96 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.86157759 |
| 97 | Supernumerary spleens (HP:0009799) | 1.86038369 |
| 98 | Meckel diverticulum (HP:0002245) | 1.84498921 |
| 99 | Exertional dyspnea (HP:0002875) | 1.84398413 |
| 100 | Acute encephalopathy (HP:0006846) | 1.83541152 |
| 101 | Abnormality of the ileum (HP:0001549) | 1.82872203 |
| 102 | Dialeptic seizures (HP:0011146) | 1.82871958 |
| 103 | Abnormality of dentin (HP:0010299) | 1.81711781 |
| 104 | Intestinal atresia (HP:0011100) | 1.80419379 |
| 105 | Respiratory failure (HP:0002878) | 1.77858201 |
| 106 | Hepatocellular necrosis (HP:0001404) | 1.77287764 |
| 107 | Nephronophthisis (HP:0000090) | 1.77159102 |
| 108 | Abnormality of cochlea (HP:0000375) | 1.76770954 |
| 109 | Stomach cancer (HP:0012126) | 1.76533646 |
| 110 | Carpal bone hypoplasia (HP:0001498) | 1.75360477 |
| 111 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.74367545 |
| 112 | Biliary tract neoplasm (HP:0100574) | 1.73725762 |
| 113 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.73590075 |
| 114 | Neoplasm of the colon (HP:0100273) | 1.72706401 |
| 115 | Myelomeningocele (HP:0002475) | 1.72457051 |
| 116 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.71674758 |
| 117 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.71674758 |
| 118 | Hyperglycinuria (HP:0003108) | 1.71452776 |
| 119 | Tubulointerstitial nephritis (HP:0001970) | 1.71029275 |
| 120 | Cerebral hypomyelination (HP:0006808) | 1.70837128 |
| 121 | Renal Fanconi syndrome (HP:0001994) | 1.70753169 |
| 122 | Broad foot (HP:0001769) | 1.70696704 |
| 123 | Hypoplastic left heart (HP:0004383) | 1.70279403 |
| 124 | Colon cancer (HP:0003003) | 1.69858110 |
| 125 | Pelvic girdle muscle weakness (HP:0003749) | 1.69815509 |
| 126 | Soft skin (HP:0000977) | 1.69745285 |
| 127 | Aplasia of the musculature (HP:0100854) | 1.69092753 |
| 128 | Slender build (HP:0001533) | 1.68551766 |
| 129 | Bile duct proliferation (HP:0001408) | 1.67667352 |
| 130 | Abnormal biliary tract physiology (HP:0012439) | 1.67667352 |
| 131 | Drooling (HP:0002307) | 1.65792764 |
| 132 | Excessive salivation (HP:0003781) | 1.65792764 |
| 133 | Impaired pain sensation (HP:0007328) | 1.63029975 |
| 134 | Abnormality of pain sensation (HP:0010832) | 1.63029975 |
| 135 | Abnormality of the astrocytes (HP:0100707) | 1.62333950 |
| 136 | Astrocytoma (HP:0009592) | 1.62333950 |
| 137 | Embryonal renal neoplasm (HP:0011794) | 1.60450081 |
| 138 | Autoamputation (HP:0001218) | 1.58978232 |
| 139 | Relative macrocephaly (HP:0004482) | 1.58853582 |
| 140 | X-linked dominant inheritance (HP:0001423) | 1.58543634 |
| 141 | Abnormality of the calf musculature (HP:0001430) | 1.57324963 |
| 142 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.56803055 |
| 143 | Type 2 muscle fiber atrophy (HP:0003554) | 1.56556413 |
| 144 | Neuroblastic tumors (HP:0004376) | 1.53264142 |
| 145 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.53264142 |
| 146 | Neuroblastoma (HP:0003006) | 1.53264142 |
| 147 | Primitive neuroectodermal tumor (HP:0030065) | 1.53264142 |
| 148 | Hypothermia (HP:0002045) | 1.52730165 |
| 149 | Agnosia (HP:0010524) | 1.51949475 |
| 150 | Abnormality of the ischium (HP:0003174) | 1.51289816 |
| 151 | Rimmed vacuoles (HP:0003805) | 1.50962170 |
| 152 | Short foot (HP:0001773) | 1.50919661 |
| 153 | Limb-girdle muscle weakness (HP:0003325) | 1.50846697 |
| 154 | Sensory axonal neuropathy (HP:0003390) | 1.50561139 |
| 155 | Birth length less than 3rd percentile (HP:0003561) | 1.50486466 |
| 156 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.50324773 |
| 157 | Hyperthyroidism (HP:0000836) | 1.50119294 |
| 158 | Delayed epiphyseal ossification (HP:0002663) | 1.49942379 |
| 159 | Freckling (HP:0001480) | 1.49438852 |
| 160 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.49323454 |
| 161 | Exercise intolerance (HP:0003546) | 1.49269064 |
| 162 | Neoplasm of the rectum (HP:0100743) | 1.48282888 |
| 163 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.48046844 |
| 164 | Spinal rigidity (HP:0003306) | 1.47698679 |
| 165 | Mesomelia (HP:0003027) | 1.45592500 |
| 166 | Hepatic necrosis (HP:0002605) | 1.45409042 |
| 167 | Congenital primary aphakia (HP:0007707) | 1.45077984 |
| 168 | Gait imbalance (HP:0002141) | 1.44359228 |
| 169 | Leukodystrophy (HP:0002415) | 1.43011915 |
| 170 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.42597832 |
| 171 | Hypoplastic ischia (HP:0003175) | 1.41882101 |
| 172 | Adrenal hypoplasia (HP:0000835) | 1.41830628 |
| 173 | Glioma (HP:0009733) | 1.41359611 |
| 174 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.41038728 |
| 175 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.39756736 |
| 176 | Absent epiphyses (HP:0010577) | 1.39756736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 3.79229308 |
| 2 | TRIM28 | 3.13861078 |
| 3 | MST4 | 2.83501156 |
| 4 | NUAK1 | 2.71380979 |
| 5 | PLK2 | 2.59439516 |
| 6 | TSSK6 | 2.42571100 |
| 7 | BCR | 2.36311893 |
| 8 | NEK1 | 2.35740629 |
| 9 | CDC7 | 2.30554041 |
| 10 | WNK3 | 2.18823090 |
| 11 | MAP3K4 | 2.15426873 |
| 12 | LIMK1 | 2.10044397 |
| 13 | MAP4K2 | 2.08800842 |
| 14 | BUB1 | 2.07352482 |
| 15 | MAP3K12 | 2.04269030 |
| 16 | MAP2K7 | 1.98279805 |
| 17 | TXK | 1.97823094 |
| 18 | PDK3 | 1.97445877 |
| 19 | PDK4 | 1.97445877 |
| 20 | STK38L | 1.96109999 |
| 21 | EIF2AK1 | 1.88788034 |
| 22 | PLK3 | 1.82861200 |
| 23 | AKT3 | 1.82551549 |
| 24 | CCNB1 | 1.82272575 |
| 25 | BRSK2 | 1.69443235 |
| 26 | PDK2 | 1.64736104 |
| 27 | BRSK1 | 1.60168968 |
| 28 | SIK3 | 1.55233076 |
| 29 | VRK2 | 1.52941632 |
| 30 | STK16 | 1.51716249 |
| 31 | PBK | 1.50369012 |
| 32 | LATS2 | 1.47924953 |
| 33 | MINK1 | 1.41838889 |
| 34 | ACVR1B | 1.37913380 |
| 35 | WEE1 | 1.37589186 |
| 36 | MKNK1 | 1.37273097 |
| 37 | ERBB3 | 1.37218304 |
| 38 | FER | 1.34982433 |
| 39 | ERBB4 | 1.30334094 |
| 40 | CDK8 | 1.25221250 |
| 41 | TEC | 1.24764258 |
| 42 | KSR1 | 1.20757488 |
| 43 | MET | 1.11964224 |
| 44 | LATS1 | 1.10786274 |
| 45 | BCKDK | 1.09873992 |
| 46 | EIF2AK2 | 1.08931936 |
| 47 | CDK19 | 1.08436944 |
| 48 | PIK3CA | 1.07628424 |
| 49 | MAP2K4 | 1.05803618 |
| 50 | TNIK | 1.04715018 |
| 51 | ZAK | 1.03723669 |
| 52 | TTK | 1.03539051 |
| 53 | CSNK1G1 | 1.03422871 |
| 54 | TIE1 | 1.02657661 |
| 55 | BRAF | 1.01349173 |
| 56 | GRK1 | 1.00979629 |
| 57 | NTRK3 | 0.97733009 |
| 58 | MOS | 0.94009994 |
| 59 | PRPF4B | 0.93571544 |
| 60 | OXSR1 | 0.92755301 |
| 61 | MELK | 0.92590015 |
| 62 | PINK1 | 0.90335609 |
| 63 | OBSCN | 0.89659240 |
| 64 | STK24 | 0.89636558 |
| 65 | CDK14 | 0.89619739 |
| 66 | MYLK | 0.89608567 |
| 67 | ADRBK1 | 0.88306036 |
| 68 | BMPR1B | 0.88110489 |
| 69 | FGFR1 | 0.88070914 |
| 70 | CDK18 | 0.87212559 |
| 71 | ADRBK2 | 0.85512894 |
| 72 | SRPK1 | 0.83716220 |
| 73 | MAPK13 | 0.83209848 |
| 74 | EPHA2 | 0.83048789 |
| 75 | TAF1 | 0.82572970 |
| 76 | FRK | 0.81966195 |
| 77 | DDR2 | 0.79424679 |
| 78 | CSNK1A1L | 0.77525789 |
| 79 | KDR | 0.77123958 |
| 80 | CAMKK2 | 0.76832406 |
| 81 | CDK15 | 0.75105870 |
| 82 | PLK1 | 0.75037908 |
| 83 | STK10 | 0.74705088 |
| 84 | RPS6KA4 | 0.73257874 |
| 85 | PRKCE | 0.70325672 |
| 86 | INSRR | 0.69924898 |
| 87 | FLT3 | 0.67942959 |
| 88 | STK39 | 0.67424910 |
| 89 | MAP2K1 | 0.66646172 |
| 90 | NEK9 | 0.66633906 |
| 91 | PRKCG | 0.66185943 |
| 92 | CSNK1G2 | 0.66153070 |
| 93 | TRPM7 | 0.65728777 |
| 94 | TESK1 | 0.65270521 |
| 95 | ARAF | 0.64956117 |
| 96 | TTN | 0.64617730 |
| 97 | AURKA | 0.63783316 |
| 98 | PLK4 | 0.63169760 |
| 99 | MKNK2 | 0.62406897 |
| 100 | NME1 | 0.61661973 |
| 101 | NEK6 | 0.61292628 |
| 102 | STK3 | 0.61090118 |
| 103 | PAK3 | 0.59567203 |
| 104 | VRK1 | 0.59447267 |
| 105 | CDK11A | 0.58445960 |
| 106 | PNCK | 0.55410937 |
| 107 | CAMK2A | 0.53657261 |
| 108 | ROCK2 | 0.52006274 |
| 109 | AURKB | 0.51383543 |
| 110 | SCYL2 | 0.50528245 |
| 111 | ITK | 0.50430772 |
| 112 | MAP3K6 | 0.50156810 |
| 113 | FES | 0.49686738 |
| 114 | CHEK2 | 0.48231817 |
| 115 | MAP3K9 | 0.48182918 |
| 116 | CSNK1G3 | 0.47643076 |
| 117 | ATM | 0.47292202 |
| 118 | ROCK1 | 0.47289094 |
| 119 | DYRK2 | 0.47094640 |
| 120 | MAP3K5 | 0.46880905 |
| 121 | FGFR2 | 0.45098394 |
| 122 | KIT | 0.43453885 |
| 123 | CAMK2B | 0.43330488 |
| 124 | ATR | 0.43279096 |
| 125 | GRK7 | 0.42847538 |
| 126 | BMPR2 | 0.42605440 |
| 127 | EIF2AK3 | 0.41964809 |
| 128 | YES1 | 0.41816255 |
| 129 | CHEK1 | 0.40395643 |
| 130 | PRKCQ | 0.39977718 |
| 131 | EGFR | 0.39614594 |
| 132 | IGF1R | 0.39533595 |
| 133 | DAPK1 | 0.39499059 |
| 134 | TGFBR1 | 0.38069670 |
| 135 | MARK3 | 0.37258617 |
| 136 | CSNK2A1 | 0.37076395 |
| 137 | PASK | 0.36618335 |
| 138 | CDK3 | 0.34763013 |
| 139 | ABL1 | 0.31634047 |
| 140 | DYRK3 | 0.31335177 |
| 141 | CSNK2A2 | 0.30203182 |
| 142 | STK4 | 0.30197831 |
| 143 | TGFBR2 | 0.28614093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.91746956 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.91578662 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.37581248 |
| 4 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.27086712 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.26051344 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.23833304 |
| 7 | Cell cycle_Homo sapiens_hsa04110 | 2.16579544 |
| 8 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.12634236 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.09702129 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.00171106 |
| 11 | Nicotine addiction_Homo sapiens_hsa05033 | 1.96323030 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.92851113 |
| 13 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.84989258 |
| 14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.81193611 |
| 15 | RNA transport_Homo sapiens_hsa03013 | 1.80447268 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.79204472 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.78922336 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.68823550 |
| 19 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.68648768 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.64531252 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.56590925 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.51652411 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.46621448 |
| 24 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.44726360 |
| 25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.41739925 |
| 26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.36252652 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34094431 |
| 28 | Mismatch repair_Homo sapiens_hsa03430 | 1.28113589 |
| 29 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.25403937 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23536138 |
| 31 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.23491919 |
| 32 | Spliceosome_Homo sapiens_hsa03040 | 1.23306939 |
| 33 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.22579162 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.20478545 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.20342997 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.18038799 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.16350498 |
| 38 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.15367320 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15123074 |
| 40 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14458715 |
| 41 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.13977266 |
| 42 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.12848244 |
| 43 | * Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.09435942 |
| 44 | Long-term potentiation_Homo sapiens_hsa04720 | 1.08704593 |
| 45 | DNA replication_Homo sapiens_hsa03030 | 1.06154275 |
| 46 | Melanoma_Homo sapiens_hsa05218 | 1.05618484 |
| 47 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.04713541 |
| 48 | GABAergic synapse_Homo sapiens_hsa04727 | 1.00011276 |
| 49 | Long-term depression_Homo sapiens_hsa04730 | 0.98751576 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.98391915 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.96496814 |
| 52 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.96238815 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.96229270 |
| 54 | RNA degradation_Homo sapiens_hsa03018 | 0.95940069 |
| 55 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.94768468 |
| 56 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.93974114 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93437696 |
| 58 | Alcoholism_Homo sapiens_hsa05034 | 0.92459448 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.91608813 |
| 60 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.91493351 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.90837632 |
| 62 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89926598 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89549294 |
| 64 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89469526 |
| 65 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.88965635 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86269923 |
| 67 | Homologous recombination_Homo sapiens_hsa03440 | 0.84973033 |
| 68 | Gap junction_Homo sapiens_hsa04540 | 0.84430749 |
| 69 | Phototransduction_Homo sapiens_hsa04744 | 0.84097560 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83994178 |
| 71 | Tight junction_Homo sapiens_hsa04530 | 0.82958998 |
| 72 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.82611391 |
| 73 | Asthma_Homo sapiens_hsa05310 | 0.81950668 |
| 74 | Axon guidance_Homo sapiens_hsa04360 | 0.81826906 |
| 75 | Morphine addiction_Homo sapiens_hsa05032 | 0.81428438 |
| 76 | Legionellosis_Homo sapiens_hsa05134 | 0.79009084 |
| 77 | Circadian entrainment_Homo sapiens_hsa04713 | 0.78563168 |
| 78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78367470 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77853650 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77532088 |
| 81 | Allograft rejection_Homo sapiens_hsa05330 | 0.75927424 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75686995 |
| 83 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.75264632 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.72978963 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72744149 |
| 86 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.72532068 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.71499949 |
| 88 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70153064 |
| 89 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69916153 |
| 90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68639882 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68516206 |
| 92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68462352 |
| 93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67471098 |
| 94 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67049754 |
| 95 | Purine metabolism_Homo sapiens_hsa00230 | 0.66780190 |
| 96 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.66609706 |
| 97 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.66317153 |
| 98 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66225525 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65231812 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64241230 |
| 101 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.63770105 |
| 102 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.61375321 |
| 103 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.61031350 |
| 104 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60461026 |
| 105 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59965673 |
| 106 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.59732391 |
| 107 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.59719807 |
| 108 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.59023182 |
| 109 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.58012440 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57640911 |
| 111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57521783 |
| 112 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.57286998 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57256473 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.57075319 |
| 115 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55639742 |
| 116 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54600619 |
| 117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53771858 |
| 118 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53596820 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53381941 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53071343 |
| 121 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.52448185 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52288418 |
| 123 | Olfactory transduction_Homo sapiens_hsa04740 | 0.51992555 |
| 124 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51426743 |
| 125 | Taste transduction_Homo sapiens_hsa04742 | 0.51070443 |
| 126 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51011353 |
| 127 | Protein export_Homo sapiens_hsa03060 | 0.50968294 |
| 128 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.49498463 |
| 129 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.48721901 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48410298 |
| 131 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.47806519 |
| 132 | Adherens junction_Homo sapiens_hsa04520 | 0.45864145 |
| 133 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.44567385 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44494110 |
| 135 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43539593 |
| 136 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42398859 |
| 137 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.42232566 |
| 138 | Melanogenesis_Homo sapiens_hsa04916 | 0.41991908 |
| 139 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38673494 |
| 140 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.36389784 |
| 141 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33585215 |
| 142 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.29594968 |
| 143 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.28011159 |
| 144 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.26154641 |
| 145 | Measles_Homo sapiens_hsa05162 | 0.25636895 |
| 146 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.23409718 |
| 147 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.22942000 |
| 148 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.20844311 |
| 149 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.20582974 |
| 150 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.16360822 |
| 151 | Shigellosis_Homo sapiens_hsa05131 | 0.15919342 |
| 152 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.14439759 |

